| 摘要 |
This invention is directed to a method of treating one or more disorders associated with an undesired downstream activity of at least one subtype of neuronal nicotinic acetylcholine receptor, comprising treating a patient with noribogaine, noribogaine derivative, or pharmaceutically acceptable salt or solvate thereof so as to attenuate said undesired effect. |
